Zobrazeno 1 - 7
of 7
pro vyhledávání: '"To, Rene M.Y."'
Autor:
Kwong, Ava, Shin, Vivian Y., Au, Chun H., Law, Fian B.F., Ho, Dona N., Ip, Bui K., Wong, Anthony T.C., Lau, Silvia S., To, Rene M.Y., Choy, Gigi, Ford, James M., Ma, Edmond S.K., Chan, Tsun L.
Publikováno v:
In The Journal of Molecular Diagnostics July 2016 18(4):580-594
Autor:
Harder, Helena, Van Gool, Arthur R., Cornelissen, Jan J., Duivenvoorden, Hugo J., Eijkenboom, Wil M.H., Barge, Rene M.Y., van den Bent, Martin J.
Publikováno v:
In European Journal of Cancer 2005 41(7):1007-1016
Autor:
Edmond S. K. Ma, Ava Kwong, Chun H Au, Silvia S. Lau, Fian B.F. Law, Dona N. Ho, Bui K. Ip, Tsun Leung Chan, Rene M.Y. To, James M. Ford, Anthony T.C. Wong, Vivian Y. Shin, Gigi Choy
Publikováno v:
The Journal of molecular diagnostics : JMD. 18(4)
Mutation in BRCA1/BRCA2 genes accounts for 20% of familial breast cancers, 5% to 10% of which may be due to other less penetrant genes which are still incompletely studied. Herein, a four-gene panel was used to examine the prevalence of BRCA1, BRCA2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5ad1f486db33a6cf6b4421a7ae3b1e
https://pubmed.ncbi.nlm.nih.gov/27157322
https://pubmed.ncbi.nlm.nih.gov/27157322
Publikováno v:
Diagnostic molecular pathology : the American journal of surgical pathology, part B. 22(3)
Activating mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer predict for a favorable clinical response to tyrosine kinase inhibitor therapy. Although Sanger sequencing is a conventional method to detect EGFR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49af4bb050fac6237015cc009b226453
https://pubmed.ncbi.nlm.nih.gov/23846439
https://pubmed.ncbi.nlm.nih.gov/23846439
Autor:
Rene M.Y. Barge, Wil M.H. Eijkenboom, Jan J. Cornelissen, Arthur R. Van Gool, Martin J. van den Bent, Helena Harder, Hugo J. Duivenvoorden
Publikováno v:
European Journal of Cancer, 41(7), 1007-1016. Elsevier Ltd.
The aim of this study was to examine cognitive performance in patients prior to bone marrow or haematopoietic stem cell transplantation (SCT) and in haematological patients who received non-myeloablative cancer therapies. A consecutive sample of 101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1c2ac00495b6b29e33167efa043c21
https://pure.eur.nl/en/publications/86d46981-dd40-40fb-99c5-187370afc92a
https://pure.eur.nl/en/publications/86d46981-dd40-40fb-99c5-187370afc92a
Publikováno v:
Diagnostic Molecular Pathology; Sep2013, Vol. 22 Issue 3, p138-143, 6p
Publikováno v:
Diagnostic Molecular Pathology; September 2013, Vol. 22 Issue: 3 p138-143, 6p